How the concept of WHO-listed authorities will change international procurement policies for medicines
Saved in:
| Main Authors: | Raffaella Ravinetto, Lembit Rägo, Cécile Macé |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-09-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/6/Suppl_3/e008109.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Europe should lead in coordinated procurement of quality-assured medicines for programmes in low-income and middle-income countries
by: Christophe Perrin, et al.
Published: (2020-07-01) -
Comparison Between Latest National Essential Medicine List and Latest WHO Essential Medicine List
by: Pradeep ., et al.
Published: (2025-01-01) -
Time to inclusion of selected medicines for priority diseases in National Essential Medicines Lists compared with the WHO Model List
by: Fatima Suleman, et al.
Published: (2025-06-01) -
Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List
by: Dzintars Gotham, et al.
Published: (2019-09-01) -
The list of authors
by: Editorial Article
Published: (2017-12-01)